| Dr Thomas Gerard Werner, DPM | |
|
2503 W Main Pl, Russellville, AR 72801-4645 | |
| (479) 968-1311 | |
| (479) 968-2704 |
| Full Name | Dr Thomas Gerard Werner |
|---|---|
| Gender | Male |
| Speciality | Podiatrist |
| Location | 2503 W Main Pl, Russellville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639105570 | NPI | - | NPPES |
| 143528748 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 81 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Gerard Werner, DPM 2503 W Main Pl, Russellville, AR 72801-4645 Ph: (479) 968-1311 | Dr Thomas Gerard Werner, DPM 2503 W Main Pl, Russellville, AR 72801-4645 Ph: (479) 968-1311 |
News Archive
Authors of a study in the September issue of the Journal of the American College of Radiology say, with an estimated $1.5 billion in potential bonus payments for radiology professionals at stake, radiologists should study and respond to recent federal regulations related to meaningful use of complete certified ambulatory electronic health records and their equivalents.
VIVUS, Inc. announced today that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form.
Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang'an Hospital, today reported its unaudited consolidated financial results for the third quarter ended September 30, 2012.
Mylan N.V. today announced the U.S. launch of Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0.03 mg, which is the generic version of Bayer's Yasmin Tablets. Mylan's partner Famy Care Ltd. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for use by women to prevent pregnancy.
By making use of model compounds in drug design, chemists at the University of California, San Diego identified a class of molecules that could lead to treatments for a wide range of diseases, including cancer, arthritis, and heart disease.
› Verified 7 days ago
Dr. Stephanie A. Roth, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 703 W Main St, Russellville, AR 72801 Phone: 479-647-6443 | |
Aquilar Foot Care Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 2400 W Main St, Russellville, AR 72801 Phone: 479-890-3668 Fax: 479-890-9513 | |
Dr. Danny J Aquilar, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2400 W Main St, Russellville, AR 72801 Phone: 479-890-3668 Fax: 479-890-9513 | |
Thomas G. Werner, D.p.m., P.a. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2503 W Main Pl, Russellville, AR 72801 Phone: 479-968-1311 Fax: 479-968-2704 | |
River Valley Foot & Ankle Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 703 W Main St, Russellville, AR 72801 Phone: 479-968-3338 | |
Reel Family Foot Clinic, P.a. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 201 E Parkway Dr, Russellville, AR 72801 Phone: 479-880-2600 Fax: 479-880-8076 |